4D Molecular Therapeutics (FDMT)
(Real Time Quote from BATS)
$15.43 USD
-0.66 (-4.10%)
Updated Aug 5, 2024 12:32 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.72 | 0.00% |
Earnings Summary
For their last quarter, 4D Molecular Therapeutics (FDMT) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-0.73 per share. This reflects a positive earnings surprise of 9.59%. Look out for FDMT's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.72 per share, reflecting a year-over-year increase of 6.49%.
Earnings History
Price & Consensus
Zacks News for FDMT
4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services